RBC Capital Markets reiterated their positive stance on Alnylam Pharmaceuticals (NASDAQ:ALNY), maintaining an Outperform rating and a price target of $300.00. According to InvestingPro data, analyst ...

RBC Capital Markets adjusted its outlook on Incyte Corporation (NASDAQ:INCY), reducing the price target to $68 from the previous $70, as the stock experiences a notable 7.85% decline over the past ...

In a report released today, Nik Modi from RBC Capital maintained a Buy rating on Edgewell Personal Care (EPC – Research Report), with a price ...

RBC Capital analyst Ashish Sabadra maintained a Buy rating on Coveo Solutions (CVO – Research Report) today and set a price target of C$11.00.

Shares of Capital Power Co. (TSE:CPX – Get Free Report) have earned a consensus rating of “Hold” from the ten brokerages that ...

Analysts suggest hedge fund will want board room shake-up, E&P focus, asset sales, spin-offs and could 'smoke out' corporate ...

Arch Capital Group Ltd. (NASDAQ:ACGL – Free Report) by 12.0% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 161,094 shares of the insurance provider’s ...

Ford reported fourth-quarter 2024 revenue and adjusted earnings per share of $48.2 billion and $0.39, respectively, ...

China Tariffs on U.S. Energy Products May Have Limited Impact -- Market Talk ...

RBC Capital Lowers Price Target for Zeta Global Holdings Corp. (ZETA) to $40, Maintains “Outperform” Rating Amid Optimism for 2025 Software Sector Ghazal Ahmed Mon, Jan 20, 2025, 12:10 PM 4 ...

Farhat is set to join Kepler Cheuvreux’s Paris office, joining from Agora Capital in Geneva, where he was head of ETF. Prior positions include stints at Tradition Securities and Lyxor ETF, and Societe ...